All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

137

Reset

137 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • BalstilimabAGEN2034Phase 23 trials

    ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer

  • BT5528nuzefatide pevedotinPhase 23 trials

    BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer

  • JAB-23E73Phase 23 trials

    Jacobio Pharmaceuticals Co., Ltd. · Advanced Solid Tumor, Advanced Solid Tumors, Metastatic Pancreatic Ductal Adenocarcinoma

  • JPI-547Phase 23 trials

    Onconic Therapeutics Inc. · Pancreatic Ductal Adenocarcinoma, Gastric Cancer (GC), Ovarian Cancer

  • PD-L1 t-haNKPhase 23 trials

    ImmunityBio, Inc. · Pancreatic Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

  • PelareorepPhase 23 trials

    Oncolytics Biotech · Anal Cancer Metastatic, Squamous Cell Carcinoma of the Anus Stage Unspecified, Pancreatic Cancer Metastatic

  • RMC-9805Phase 23 trials

    Revolution Medicines, Inc. · PDAC, Colorectal Cancer, CRC

  • RNK08954Phase 23 trials

    InxMed (Shanghai) Co., Ltd. · Solid Tumor Cancer, PDAC, KRAS G12D Mutations

  • SSGJ-706Phase 23 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Non Small Cell Lung Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC)

  • TNG462Phase 23 trials

    Tango Therapeutics, Inc. · MTAP-deleted Solid Tumors, Locally Advanced Solid Tumor, PDAC

  • BEY1107Phase 22 trials

    BeyondBio Inc. · Metastatic Colorectal Cancer, Locally Advanced or Metastatic Pancreatic Cancer

  • BLEX 404Phase 22 trials

    Rgene Corporation · Pancreatic Cancer, Nonsquamous Nonsmall Cell Neoplasm of Lung

  • CVM-1118TRX-818Phase 22 trials

    TaiRx, Inc. · Hepatocellular Carcinoma, Advanced Cancer, Neuroendocrine Tumors

  • EB-DNK101 dual-targeting CAR-NK cellsMSLN + MUC1Phase 22 trials

    Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced

  • EB-DNK102 dual-targeting CAR-NK cellsCLDN18.2 + MUC1Phase 22 trials

    Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced

  • ERAS-007Phase 22 trials

    Erasca, Inc. · Advanced or Metastatic Solid Tumors, Metastatic Colorectal Cancer, Metastatic Pancreatic Ductal Adenocarcinoma

  • GKL-006iNKT cellsPhase 22 trials

    Beijing Gene Key Life Technology Co., Ltd · Advanced Pancreatic Cancer, Ductal Adenocarcinoma of Pancreas, Hepatocellular Carcinoma (HCC)

  • ImzokitugBMS-986340Phase 22 trials

    Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer

  • KN046Recombinant Humanized PD-L1, CTLA-4 Bispecific Single Domain Antibody Fc Fusion ProteinPhase 22 trials

    InxMed (Shanghai) Co., Ltd. · Pancreatic Cancer, Advanced Non-small Cell Lung Cancer

  • NLM-001Phase 22 trials

    Nelum Corp · Untreated, Advanced Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma

  • ODM-212Phase 22 trials

    Orion Corporation, Orion Pharma · Solid Tumours, Mesothelioma, Pancreatic Cancer

  • Olaptesed pegolNOX-A12Phase 22 trials

    TME Pharma AG · Metastatic Pancreatic Cancer, Glioblastoma

  • SelicrelumabPhase 22 trials

    Roche (Genentech) · Metastatic Breast Cancer, Pancreatic Adenocarcinoma

  • TQB2916Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Soft Tissue Sarcoma, Melanoma, Pancreatic Cancer

  • TST001Phase 22 trials

    Transcenta Therapeutics (Hangzhou) Co., Ltd. · Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer

  • XNW27011ASP546CPhase 22 trials

    Astellas · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic

  • ZalifrelimabPhase 22 trials

    ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer

  • AFNT-211Phase 21 trial

    Affini-T Therapeutics, Inc. · Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, Colorectal Cancer

  • Aldoxorubicin HClPhase 21 trial

    ImmunityBio, Inc. · Pancreatic Cancer

  • AMP945Phase 21 trial

    Amplia Therapeutics Limited · Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma

  • AMXI-5001Phase 21 trial

    AtlasMedx, Incorporated · Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer

  • ANG003Phase 21 trial

    Anagram Therapeutics, Inc. · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)

  • ANO31905Phase 21 trial

    Anova Innovation Limited · Pancreatic Cancer

  • ART0380Phase 21 trial

    Artios Pharma Ltd · Advanced Cancer, Metastatic Cancer, Ovarian Cancer

  • AZD4360Phase 21 trial

    AstraZeneca · Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer

  • AZD5863Phase 21 trial

    AstraZeneca · Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma

  • BalstililmabPhase 21 trial

    Nelum Corp · Untreated, Advanced Pancreatic Cancer

  • BLU-924SAR449336Phase 21 trial

    Blueprint Medicines Corporation · Advanced Solid Tumor, Non-Small Cell Lung Cancer, Colorectal Neoplasms

  • BMS-986523Phase 21 trial

    Bristol Myers Squibb · Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)

  • BPI-572270Phase 21 trial

    Betta Pharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC)

  • CP-383Phase 21 trial

    Tasca Therapeutics · Solid Tumor Malignancies, Colorectal Carcinoma, Small Cell Lung Cancer ( SCLC )

  • CT041Phase 21 trial

    CARsgen Therapeutics Co., Ltd. · Gastric Cancer, Pancreatic Cancer

  • CT3001Phase 21 trial

    Crossignal Therapeutics, Inc. · Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma

  • Decoy20Phase 21 trial

    Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)

  • DM002Phase 21 trial

    Xadcera Biopharmaceutical (Suzhou) Co., Ltd. · Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

  • EF-009Phase 21 trial

    Everfront Biotech Co., Ltd. · Pancreatic Cancer

  • EfineptakinNT-I7, rhIL-7-hyFcPhase 21 trial

    NeoImmuneTech · Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer

  • ERAS-0015Phase 21 trial

    Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC

  • ETX-929Phase 21 trial

    Ensem Therapeutics · Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Non-squamous, Non-Small Cell Lung Cancer

  • GEN1042Phase 21 trial

    Genmab · Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)

NewerPage 2 of 3Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.